$GNBT #OTCQB Generex Biotechnology Corp. (GNBT: OTCQB) | Generex Subsidiary NGIO Advances COVID-19 Vaccine Program with the Manufacturing of Patent-Pending Ii-Key-SARS-CoV-2 Peptides
Copyright 2019 – OTC Markets Group Inc.

News Link